Multiple Sclerosis Association, Antidote Technologies Collaborate to Raise Clinical-trial Awareness
The Multiple Sclerosis Association of America (MSAA) and Antidote TechnologiesĀ announced a partnership to increase awareness aboutĀ clinical trials on multiple sclerosis (MS) and to make important information more accessible. In addition to helping those with the disease, the effort aims to help companies planning trials to find participants for…